| - Industry | - Sector | - CEO | XNSE Exchange | - ISIN |
| India Country | 3,230 Employees | - Last Dividend | - Last Split | - IPO Date |
Nephrocare Health Services Limited is India's foremost provider of dialysis care, committed to delivering a comprehensive range of renal-care services through a wide network of clinics across India and certain international locations, including the Philippines and Uzbekistan. Offering innovative solutions such as haemodialysis, peritoneal dialysis, home haemodialysis, dialysis-on-call, and dialysis-on-wheels, the company addresses the complex needs of patients requiring renal support. In addition to these services, Nephrocare extends pharmacy support, diagnostics, and wellness management to enhance patient care.
The company operates a diverse set of facilities including captive hospital-based clinics, standalone centers, and notably, large Public-Private Partnership units. This extensive presence in tier II and III cities strategically targets regions that are often underserved by healthcare services. Nephrocare has established partnerships with respected hospital chains such as Max, Fortis, and Wockhardt to oversee the management of in-house dialysis centers, ensuring access to quality care.
Founded in 2010 and headquartered in Hyderabad, India, Nephrocare leverages an asset-light business model that prioritizes operational efficiency. This is achieved through centralized procurement, contract manufacturing of essential consumables, and the incorporation of advanced technology innovations, including the proprietary Renova reprocessing system. Furthermore, the company utilizes AI-driven tools and digital patient platforms to enhance the overall patient experience. Clinical excellence is supported by RenAssure protocols and the Enpidia training academy, reinforcing Nephrocare's commitment to high-quality care in the rapidly expanding renal healthcare sector.